- Conditions
- Critical Illness
- Interventions
- Parenteral Nutrition, Propofol, Clevidipine, Dextrose-containing IV Fluids, Enteral feeding
- Drug
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 73–96
of 194
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Cholestasis of Parenteral Nutrition
- Interventions
- Omegaven 10%
- Drug
- Lead sponsor
- Georgetown University
- Other
- Eligibility
- 2 Months to 18 Years
- U.S. locations
- 2
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Endocarditis, Bacterial, Opioid-use Disorder, Buprenorphine, Outpatient Parenteral Antibiotic Therapy
- Interventions
- Outpatient parenteral antibiotic therapy
- Behavioral
- Lead sponsor
- Laura Fanucchi
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Parenteral Nutrition Associated Liver Disease
- Interventions
- Omegaven
- Drug
- Lead sponsor
- St. Luke's Health System, Boise, Idaho
- Other
- Eligibility
- Up to 17 Years
- U.S. locations
- 1
- States / cities
- Boise, Idaho
- Conditions
- Intestinal Failure, Hypoglycemia, Hyperglycemia
- Interventions
- Not listed
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 2 Months to 18 Months
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Cholestasis, Liver Diseases
- Interventions
- Omegaven
- Drug
- Lead sponsor
- Catherine Cibulskis, MD
- Other
- Eligibility
- Up to 1 Year
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Short Bowel Syndrome
- Interventions
- WHO ORS, Commercial ORS
- Dietary Supplement
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Drug Use, Opioid-use Disorder
- Interventions
- Buprenorphine and Outpatient Parenteral Antibiotic Therapy, Buprenorphine and standard of care antibiotic treatment
- Drug
- Lead sponsor
- Laura Fanucchi
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 71 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Obesity, Over-weight, Prader-Willi Syndrome
- Interventions
- ZGN-440 sterile diluent, 1.2 mg ZGN-440 for injectable suspension, 1.8 mg ZGN-440 for injectable suspension
- Drug
- Lead sponsor
- Zafgen, Inc.
- Industry
- Eligibility
- 16 Years to 65 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Sepsis
- Interventions
- Glutamine, Placebo
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 72 Hours
- Enrollment
- 1,433 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1999 – 2001
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Palo Alto, California • San Diego, California + 12 more
- Conditions
- Parenteral Nutrition Associated Liver Disease
- Interventions
- Lovaza (fish oil)
- Drug
- Lead sponsor
- University of Tennessee
- Other
- Eligibility
- 1 Day to 1 Year
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2014
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- Total Parenteral Nutrition-induced Cholestasis
- Interventions
- Omegaven®
- Drug
- Lead sponsor
- Jeffrey Rudolph
- Other
- Eligibility
- 2 Months to 10 Years
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Parenteral Nutrition Associated Cholestasis
- Interventions
- Omegaven
- Drug
- Lead sponsor
- Arthur J De Lorimier
- Other
- Eligibility
- Up to 1 Year
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2018
- U.S. locations
- 1
- States / cities
- Sacramento, California
- Conditions
- HIV Infections
- Interventions
- Dextrin 2-sulfate
- Drug
- Lead sponsor
- Steinhart Medical Associates
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 1999
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Advanced Cancer
- Interventions
- Phone Interview/Questionnaire
- Behavioral
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 74 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2020
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Infant, Newborn, Disease
- Interventions
- Manganese omission, 5 mCg/kg/day manganese from "Multitrace-4 Neonatal."
- Other
- Lead sponsor
- Sharp HealthCare
- Other
- Eligibility
- Up to 1 Day
- Enrollment
- 26 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Short Bowel Syndrome
- Interventions
- Placebo, Teduglutide 0.05 mg/kg/d, Teduglutide 0.1 mg/kg/d
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 84 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 14
- States / cities
- Scottsdale, Arizona • Washington D.C., District of Columbia • Atlanta, Georgia + 11 more
- Conditions
- Intestinal Failure-associated Liver Disease
- Interventions
- Not listed
- Lead sponsor
- Protara Therapeutics
- Industry
- Eligibility
- 12 Years to 80 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 10
- States / cities
- Los Angeles, California • Kissimmee, Florida • Chicago, Illinois + 7 more
- Conditions
- Cancer
- Interventions
- Home Parenteral Nutrition
- Dietary Supplement
- Lead sponsor
- Southwestern Regional Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Tulsa, Oklahoma
- Conditions
- Short Bowel Syndrome
- Interventions
- teduglutide, placebo
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 11
- States / cities
- La Jolla, California • Washington D.C., District of Columbia • Jacksonville, Florida + 8 more
- Conditions
- Critical Illness, Acute Respiratory Failure
- Interventions
- Olimel (5.7%E / N9E)
- Drug
- Lead sponsor
- Clinical Evaluation Research Unit at Kingston General Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 125 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 7
- States / cities
- Boulder, Colorado • St Louis, Missouri • Cleveland, Ohio + 3 more
- Conditions
- Cholestasis
- Interventions
- Omegaven
- Drug
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- Up to 18 Years
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 2
- States / cities
- San Diego, California
- Conditions
- Liver Injury
- Interventions
- Omegaven™, Historical Controls
- Drug · Other
- Lead sponsor
- Children's Hospital Los Angeles
- Other
- Eligibility
- Up to 21 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2019
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Central Line Associated Blood Stream Infections (CLABSI)
- Interventions
- (taurolidine and heparin) catheter lock solution, Heparin
- Drug
- Lead sponsor
- CorMedix Therapeutics
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 19
- States / cities
- Los Angeles, California • Washington D.C., District of Columbia • Doral, Florida + 14 more